The Glycometabolism Abnormality among Schizophrenia Patients
吴小立,魏钦令,钟智勇,赵靖平,郑俩荣,李雷俊,唐秀梅
DOI: https://doi.org/10.3760/cma.j.issn.1006-7884.2012.06.002
2012-01-01
Abstract:Objective To explore the potential glycometabolism abnormality and the related factors of schizophrenia patients in China.Methods This cross-sectional study included 44 healthy controls (group 1) and 178 inpatient schizophrenia patients,including 71 drug-naive first-episode patients (group 2),68 patients with continuous antipsychotics medication of ≥ 1 year (group 3) and 39 patients with continuous antipsychotics medication of ≥ 1 year and drug withdrawal of ≥ 3 months (group 4).At baseline,the demographic characteristics were collected.The weight,height,waistline,hipline,fasting blood glucose,fasting insuline and fasting C-peptide level were measured.The Positive and Negative Syndrome Scale (PANSS) were assessed in patients.Results (1) Group 2 showed a higher level of INS,C-peptide,IR [(8.50 ± 4.89) mU/L,(0.44 ± 0.19) nmol/L,1.84 ± 1.15] than group 1 [(5.96 ± 2.15) mU/L,(0.30 ±0.07) nmol/L,1.27 ± 0.51] (t =-3.83,-5.29,-3.56 ; P ＜ 0.01),and its WHR (0.82 ± 0.06) was larger than group 1 (0.79 ± 0.06 ;t =-1.92,P =0.05).(2) Group 3 showed a much higher level of BMI,waistline,WHR,INS and IR[(23.20 ± 3.72) kg/m2,(81.60 ± 10.32) cm,0.88 ± 0.06,(12.14 ± 6.63)mU/L,2.64 ± 1.43] than group 2 [(19.62 ±2.51) kg/m2,(70.42±7.57) cm,0.82±0.06,(8.50±4.89) mU/L,1.84 ± 1.15] (t = 6.58,7.21,5.39,3.66,Ps ＜ 0.01),and its fasting C-peptide level (0.53 ±0.22) nmol/L was higher than group 2 (0.44 ± 0.19) nmol/L (t =2.50,P ＜ 0.05).(3) Group 4 showed lower waistline and WHR [(79.01 ± 10.93) cm,0.86 ± 0.08] than group 3 [(81.60 ± 10.32) cm,0.88 ±0.06] (t =4.30,4.79;Ps ＜0.05),however,the glyeometabolism parameters between groups had no difference (P ＞ 0.05).Conclusions These findings suggest that the schizophrenia patients maybe have some impairment of synthesis and utilization of insulin,and antipsychotics treatment could exacerbate glycometabolic disturbances.